Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuraxis (NRXS) EBT Margin (2022 - 2025)

Neuraxis' EBT Margin history spans 4 years, with the latest figure at 262.47% for Q3 2025.

  • For Q3 2025, EBT Margin fell 1346.0% year-over-year to 262.47%; the TTM value through Sep 2025 reached 209.42%, up 9910.0%, while the annual FY2024 figure was 266.54%, 479.0% up from the prior year.
  • EBT Margin for Q3 2025 was 262.47% at Neuraxis, down from 193.64% in the prior quarter.
  • Across five years, EBT Margin topped out at 1294.27% in Q3 2022 and bottomed at 632.89% in Q3 2023.
  • The 4-year median for EBT Margin is 240.02% (2023), against an average of 145.72%.
  • The largest annual shift saw EBT Margin tumbled -192717bps in 2023 before it soared 38388bps in 2024.
  • A 4-year view of EBT Margin shows it stood at 160.86% in 2022, then tumbled by -49bps to 240.02% in 2023, then soared by 52bps to 116.01% in 2024, then tumbled by -126bps to 262.47% in 2025.
  • Per Business Quant, the three most recent readings for NRXS's EBT Margin are 262.47% (Q3 2025), 193.64% (Q2 2025), and 256.5% (Q1 2025).